U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
135451135451Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV MelanomaActive, not recruitingNo Results AvailableMelanomaDrug: Bevacizumab Plus Ipilimumab Cohort 1|Drug: Bevacizumab Plus Ipilimumab Cohort 2|Drug: Bevacizumab Plus Ipilimumab Cohort 3|Drug: Bevacizumab Plus Ipilimumab Cohort 4https://ClinicalTrials.gov/show/NCT00790010
135452135452TNF-alpha Antagonists for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailableCOPD ExacerbationDrug: Etanercept + Levofloxacin + placebo prednisone capsules|Drug: Prednisone + Levofloxacin + placebo Etanercept subcutaneous injectionshttps://ClinicalTrials.gov/show/NCT00789997
135453135453Corneal Specular Microscopy in Infectious and Noninfectious UveitisCompletedNo Results AvailableUveitisDevice: noncontact specular microscopyhttps://ClinicalTrials.gov/show/NCT00789984
135454135454Triamcinolone Versus Topical Treatment in Post Operative PhacoemulsificationCompletedNo Results AvailableOcular InflammationDrug: triamcinolone acetonide|Drug: Maxitriolhttps://ClinicalTrials.gov/show/NCT00789971
135455135455S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctActive, not recruitingNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder CancerDrug: capecitabine|Drug: gemcitabine hydrochloride|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapyhttps://ClinicalTrials.gov/show/NCT00789958
135456135456Timing of Insulin Before Meals EverydayCompletedNo Results AvailableType 1 DiabetesOther: Control|Other: Study Arm Bhttps://ClinicalTrials.gov/show/NCT00789945
135457135457Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled TrialCompletedNo Results AvailableAutism Spectrum DisorderBehavioral: cognitive behavioral therapy|Behavioral: Usual community carehttps://ClinicalTrials.gov/show/NCT00789932
135458135458Mild Preeclampsia Near Term: Deliver or Deliberate?CompletedNo Results AvailablePreeclampsiaProcedure: Delivery of infanthttps://ClinicalTrials.gov/show/NCT00789919
135459135459Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in SchizophreniaRecruitingNo Results AvailableSchizophreniahttps://ClinicalTrials.gov/show/NCT00789906
135460135460Study of Vaginal Dilator Use After Pelvic RadiotherapyCompletedNo Results AvailableCervical Cancer|Endometrial Cancer|Rectal Cancer|Anal CancerDevice: Vaginal Dilatorhttps://ClinicalTrials.gov/show/NCT00789893
135461135461Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3CompletedHas ResultsAtopic Dermatitis|PsoriasisDrug: Vitamin D3|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00789880
135462135462Single Dose of pGM169/GL67A in CF PatientsCompletedNo Results AvailableCystic FibrosisDrug: pGM169/GL67Ahttps://ClinicalTrials.gov/show/NCT00789867
135463135463Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsCompletedHas ResultsMajor Depressive Disorder|Treatment Resistant DepressionDrug: Quetiapine XR|Drug: Lithium carbonate|Drug: SSRI/Venlafaxinehttps://ClinicalTrials.gov/show/NCT00789854
135464135464Gastrointestinal Motility in Patients With Neuroendocrine TumorsCompletedNo Results AvailableNeuroendocrine TumorDevice: Magnetic Tracking System (MTS) and radio-opaque markershttps://ClinicalTrials.gov/show/NCT00789841
135465135465Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)CompletedHas ResultsTuberous Sclerosis|Subependymal Giant Cell AstrocytomaDrug: Everolimus|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00789828
135466135466Bispectral Index-guided Sedation for Flexible BronchoscopyCompletedHas ResultsFlexible BronchoscopyDevice: Bispectral index guide propofol infusion|Drug: Clinical-judged midazolam administrationhttps://ClinicalTrials.gov/show/NCT00789815
135467135467A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUCCompletedHas ResultsContraception|BleedingDrug: transdermal estradiol|Drug: naproxen|Drug: oral placebohttps://ClinicalTrials.gov/show/NCT00789802
135468135468Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine TrialsRecruitingNo Results AvailableHIV Infection|HIV Seronegativityhttps://ClinicalTrials.gov/show/NCT00789789
135469135469Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic CancerRecruitingNo Results AvailableAcute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Diffuse Large B-Cell Lymphoma|Previously Treated Myelodysplastic Syndrome|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Procedure: Allogeneic Bone Marrow Transplantation|Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Mycophenolate Mofetil|Biological: Natural Killer Cell Therapy|Drug: Tacrolimus|Radiation: Total-Body Irradiationhttps://ClinicalTrials.gov/show/NCT00789776
135470135470Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNo Results AvailablePancreatic CancerDrug: Gemcitabine|Radiation: Radiotherapy|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT00789763
135471135471Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Welchol|Drug: placebo|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT00789750
135472135472Welchol as Monotherapy for Type 2 Diabetes MellitusCompletedHas ResultsType 2 Diabetes MellitusDrug: Welchol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00789737
135473135473Anakinra to Prevent Post-infarction RemodelingCompletedHas ResultsST Segment Elevation Acute Myocardial InfarctionDrug: Anakinra|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00789724
135474135474An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2Drug: biphasic insulin aspart 30|Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT00789711
135475135475Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic SchizophreniaCompletedHas ResultsChronic SchizophreniaDrug: Lurasidone HC1|Drug: Quetiapine XRhttps://ClinicalTrials.gov/show/NCT00789698
135476135476Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/IICompletedHas ResultsAcute Lung Injury|Acute Respiratory Distress SyndromeDrug: Interferon Betahttps://ClinicalTrials.gov/show/NCT00789685
135477135477Pilot Study to Evaluate Levodopa as Treatment for Residual AmblyopiaCompletedHas ResultsAmblyopiaDrug: levodopa/carbidopa|Device: patching|Drug: levodopa/carbidopahttps://ClinicalTrials.gov/show/NCT00789672
135478135478Incisional Wound Vac in Obese PatientsActive, not recruitingNo Results AvailableWound Infection|Postoperative ComplicationOther: Negative pressure dressinghttps://ClinicalTrials.gov/show/NCT00789659
135479135479Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer PatientsEnrolling by invitationNo Results AvailableCorneal UlcerProcedure: Lidocaine/NSS|Procedure: NSS/Lidocainehttps://ClinicalTrials.gov/show/NCT00789646
135480135480A Phase 3 Study to Compare Efficacy and Safety of Masitinib in Combination With Gemcitabine, to Placebo in Combination With Gemcitabine, in Treatment of Patients With Advanced/Metastatic Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: masitinib (AB1010)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00789633

* Görseller ve İçerik tekif hakkına sahip olabilir